4//SEC Filing
Enavate Sciences GP, LLC 4
Accession 0001415889-24-025354
CIK 0001736730other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:15 PM ET
Size
11.5 KB
Accession
0001415889-24-025354
Insider Transaction Report
Form 4
Enavate Sciences GP, LLC
10% Owner
Transactions
- Purchase
Common Stock
2024-10-15$11.00/sh+1,363,636$14,999,996→ 3,785,802 total(indirect: By Everest Aggregator, LP) - Conversion
Common Stock
2024-10-15+2,422,166→ 2,422,166 total(indirect: By Everest Aggregator, LP) - Conversion
Series B Preferred Stock
2024-10-15−27,166,530→ 0 total(indirect: By Everest Aggregator, LP)→ Common Stock (2,422,166 underlying)
Everest Aggregator, LP
10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+2,422,166→ 2,422,166 total(indirect: By Everest Aggregator, LP) - Purchase
Common Stock
2024-10-15$11.00/sh+1,363,636$14,999,996→ 3,785,802 total(indirect: By Everest Aggregator, LP) - Conversion
Series B Preferred Stock
2024-10-15−27,166,530→ 0 total(indirect: By Everest Aggregator, LP)→ Common Stock (2,422,166 underlying)
Footnotes (2)
- [F1]Each share of Series B Preferred Stock (the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
- [F2]Shares are directly held by Everest Aggregator, LP ("Everest"). Enavate Sciences GP, LLC ("Enavate") is the general partner of Everest and may be deemed to share voting and investment power with respect to the shares held by Everest. Enavate disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Camp4 Therapeutics Corp
CIK 0001736730
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001953107
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:15 PM ET
- Size
- 11.5 KB